NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Oncosoft

Oncosoft

Private
SeoulHealthcare & Life Scienceshttps://oncosoft.io/

Last Round

VC Round

Jul 2, 2026

Total Funding Raised

$10.66M

Company Overview

Oncosoft is a medical technology company that develops AI-based software solutions for radiation oncology, including automated organ contouring and radiotherapy workflow management.

Sector

Healthcare & Life Sciences

Verticals

Medical AI, Medical Imaging, Healthcare Analytics, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Services & Consulting

AI Layer

Application

Keywords

radiation oncologyauto-contouringmedical imaging AIradiotherapy planningclinical AIworkflow automationdigital healthhealth techDICOMHL7 FHIRFHIRradiopharmaceutical therapyparticle therapymedical softwareSaaS

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Oncosoft Comps

Public and private peers based on sector, stage, and business model.

Oncosoft comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Oncosoft Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
VC RoundJul 2, 2026
Series BSep 23, 2024
Series ASep 1, 2022
VC RoundJul 1, 2021
SeedOct 1, 2020

Oncosoft Investors

Notable investors and investment history

Oncosoft investors
InvestorRounds
BNH INVESTMENTSeries B
Korea Investment & SecuritiesVC Round
Comes InvestmentVC Round
BonAngels Venture PartnersSeries B
WantedLab PartnersVC Round
G.N.Tech Venture CapitalVC Round
HB InvestmentVC Round, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 9, 2025

    Grew 20% QoQ, from 15 to 18 employees.

Oncosoft Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Oncosoft Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Oncosoft's valuation, stock price, and market status.

Firmographic Details

HeadquartersSeoul
Employee Range22
Year Founded2019
Last FundingJul 2, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.